Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Firsov

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Antibiotiki|March 1, 1983
[Experimental and clinical data on the ototoxic properties of aminoglycoside antibiotics (aminocyclitols)]V V Berezhinskaia, G V Dolgova, A A Eĭromdzhants, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|October 1, 1991
[Pharmacokinetic monitoring of aminoglycoside therapy: an optimal method of administration of individualized doses of gentamicin and sisomicin]A A Firsov, M E Alekseeva, G I Lukomskiĭ, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|July 1, 1990
[Hypotension caused by intravenous infusion of rifampicin and its relation to the administration schedule]V V Berezhinskaia, G V Dolgova, A A Firsov, et al.
Chemotherapy|April 4, 2003
Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parametersA A Firsov, S H Zinner, I Y Lubenko, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|March 15, 2018
Concentration-Dependent Enrichment of Linezolid-Resistant Staphylococcus aureus in an in vitro Dynamic ModelK N Alieva, E N Strukova, M V Golikova, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratioS N Vostrov, O V Kononenko, I Y Lubenko, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Relationships of the area under the curve/MIC ratio to different integral endpoints of the antimicrobial effect: gemifloxacin pharmacodynamics in an in vitro dynamic modelA A Firsov, I Y Lubenko, Y A Portnoy, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 1, 1989
[Kinetics of the antibacterial effect of ampicillin and sulbactam combinations in dynamic and static conditions]A D Nazarov, V M Chernykh, L N Samoĭlova, et al.
Antibiotiki|April 1, 1980
[Pharmacokinetic validation of the nephrotoxic action of sisomycin. The relationship between nephrotoxicity and sisomycin concentration in the blood serum of rats]A A Firsov, G G Egorenko, E K Berezina, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 1, 1990
[Individualization of the amikacin administration regimen on the basis of the relationship between its pharmacokinetics and the patient's status]A A Firsov, V N Nasonov, S A Murav'eva, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Antibiotiki|March 1, 1983
[Experimental and clinical data on the ototoxic properties of aminoglycoside antibiotics (aminocyclitols)]V V Berezhinskaia, G V Dolgova, A A Eĭromdzhants, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|October 1, 1991
[Pharmacokinetic monitoring of aminoglycoside therapy: an optimal method of administration of individualized doses of gentamicin and sisomicin]A A Firsov, M E Alekseeva, G I Lukomskiĭ, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|July 1, 1990
[Hypotension caused by intravenous infusion of rifampicin and its relation to the administration schedule]V V Berezhinskaia, G V Dolgova, A A Firsov, et al.
Chemotherapy|April 4, 2003
Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parametersA A Firsov, S H Zinner, I Y Lubenko, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|March 15, 2018
Concentration-Dependent Enrichment of Linezolid-Resistant Staphylococcus aureus in an in vitro Dynamic ModelK N Alieva, E N Strukova, M V Golikova, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratioS N Vostrov, O V Kononenko, I Y Lubenko, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Relationships of the area under the curve/MIC ratio to different integral endpoints of the antimicrobial effect: gemifloxacin pharmacodynamics in an in vitro dynamic modelA A Firsov, I Y Lubenko, Y A Portnoy, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 1, 1989
[Kinetics of the antibacterial effect of ampicillin and sulbactam combinations in dynamic and static conditions]A D Nazarov, V M Chernykh, L N Samoĭlova, et al.
Antibiotiki|April 1, 1980
[Pharmacokinetic validation of the nephrotoxic action of sisomycin. The relationship between nephrotoxicity and sisomycin concentration in the blood serum of rats]A A Firsov, G G Egorenko, E K Berezina, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 1, 1990
[Individualization of the amikacin administration regimen on the basis of the relationship between its pharmacokinetics and the patient's status]A A Firsov, V N Nasonov, S A Murav'eva, et al.
Pageof 11